Stock futures drop as key tech tumbles

by / ⠀News / January 14, 2025
Stock futures drop as key tech tumbles

U.S. stock futures slid on Monday as key tech stocks took a hit.

The Nasdaq futures dropped more than 1%, shedding 0.9%, while futures tied to the Dow lost 36 points, or 0.1%. Major benchmarks have been down for the last two weeks, with tech shares causing most of the decline.

Palantir and Nvidia, two of the bull market leaders popular with retail investors, each shed around 3% in premarket trading. Other tech shares, including Tesla, Broadcom, and Micron, were also down. Surging bond yields have been a catalyst for the sell-off in growth-oriented shares.

On Monday, the 10-year Treasury yield touched its highest level since late 2023.

“With current inflation and inflation expectations elevated and sticky, and with bond yields rising sharply and quickly, equity investors are becoming more cautious,” said Katherine Nixon, chief investment officer for wealth management at Northern Trust. A better-than-expected jobs report on Friday spiked yields and sent stocks reeling by casting doubt on further interest rate cuts by the Federal Reserve.

See also  CoinStats wallet breach affects numerous users

The Dow lost 697 points on Friday. All three major indexes are now in the red for the year. Investors are hoping that the start of the fourth-quarter earnings season will stabilize markets.

Tech stocks tumble amid rising yields

Banks, including JPMorgan and Citigroup, report earnings on Wednesday, while Delta Air Lines will post results on Thursday. Key economic data this week includes the December consumer price index on Wednesday morning.

Before that, investors will analyze wholesale inflation with December’s producer price index report on Tuesday. In other market news, shares of clothing retailer Abercrombie & Fitch plunged 11% in premarket trading despite strong holiday sales expectations. Pinterest shares slid 3% following a downgrade by Jefferies.

However, shares of real estate developer Howard Hughes Corp. jumped 9% after Bill Ackman’s Pershing Square proposed forming a new subsidiary that would merge with the company. Barclays also dialed back its optimism on small cap stocks, downgrading its outlook to neutral from positive due to rising yields.

In corporate news, Johnson & Johnson announced it will acquire Intra-Cellular Therapies for $14.6 billion. Shares of Intra-Cellular soared 35.5% on the news. Asia markets fell Monday as traders assessed the U.S. jobs report and China trade data.

Mainland China’s benchmark CSI 300 extended losses, while Hong Kong’s Hang Seng Index was also down. China’s central bank pledged to enhance the management of the foreign exchange market and prevent any risk of yuan “overshooting” during a meeting held in Beijing.

About The Author

Erica Stacey

Erica Stacey is an entrepreneur and business strategist. As a prolific writer, she leverages her expertise in leadership and innovation to empower young professionals. With a proven track record of successful ventures under her belt, Erica's insights provide invaluable guidance to aspiring business leaders seeking to make their mark in today's competitive landscape.

x

Get Funded Faster!

Proven Pitch Deck

Signup for our newsletter to get access to our proven pitch deck template.